IBAB Ion Beam Applications SA

IBA Notice of Half Year 2023 Results and Conference Call

IBA Notice of Half Year 2023 Results and Conference Call

HY23 results meeting to take place as a hybrid event on

Thursday, 31 August 2023 at 3 pm CEST

Louvain-la-Neuve, Belgium, 27 July 2023 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the half year 2023 on Thursday, 31 August 2023 at 7 am CEST.

Conference Call Information

Olivier Legrain, Chief Executive Officer, and Soumya Chandramouli, Chief Financial Officer, will host a hybrid event, including a conference call and webcast conducted in English, to present the half year results, followed by a Q&A session.

The conference call will be held on Thursday, 31 August 2023 at 3 pm CEST / 2 pm BST / 9 am EDT / 6 am PDT as a Teams webinar and can be accessed .

If you would like to join by phone only, please dial (Phone conference ID 307 168 530#):

Belgium:                    

UK:                             0

NL:                             

LU:                              2

US:                            

FR:                              51

The presentation will be available on website and on:

shortly before the call.

To ensure a timely connection, it is recommended that users register at least 10 minutes prior to the scheduled webcast.

For participants who do not have the Teams application installed, please follow the process described in to access the conference.

ENDS

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 1,800 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at:

CONTACTS

Soumya Chandramouli

Chief Financial Officer



Olivier Lechien

Corporate Communication Director



Consilium Strategic Communications

Amber Fennell, Matthew Neal, Lucy Featherstone

+44 (0) 20 3709 5700

Attachment



EN
27/07/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ion Beam Applications SA

Guy Sips ... (+2)
  • Guy Sips
  • Michiel Declercq
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

IBA: Large X-ray sterilisation solution sale Proximus: Stijn Bijnens new CEO of Proximus

 PRESS RELEASE

Steri-Tek to boost sterilization capacity of its Texas-based center fi...

Steri-Tek to boost sterilization capacity of its Texas-based center fivefold with IBA’s X-ray irradiation system Louvain-la-Neuve, Belgium, June 18, 2025 –  (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced irradiation, announced today it has signed a contract with Steri-Tek, a growing irradiation services provider, to install a fully-integrated Be Wide X-ray Solution. IBA’s solution will be installed at Steri-Tek’s service center near Dallas-Fort Worth Metro Area, Texas, which was op...

 PRESS RELEASE

 Steri-Tek va quintupler la capacité de stérilisation de son centre au...

 Steri-Tek va quintupler la capacité de stérilisation de son centre au Texas avec un système d’irradiation par rayons X d’IBA Louvain-la-Neuve, Belgique, le 18 juin 2025 - IBA (Ion Beam Applications S.A.), le leader mondial des technologies d’accélération de particules et des solutions de pointe d'irradiation industrielle par faisceau d'électrons et rayons X, annonce aujourd'hui avoir signé un contrat avec Steri-Tek, un fournisseur de services d'irradiation en pleine croissance, pour installer une solution d’irradiation par rayons X, Be Wide, entièrement intégrée. La solution d'IBA sera ...

 PRESS RELEASE

Procès-verbal de l'Assemblée Générale Ordinaire d'IBA et résultats des...

Procès-verbal de l'Assemblée Générale Ordinaire d'IBA et résultats des votes Information réglementée Assemblée Générale Ordinaire du 11 juin 2025 Belgique, le 16 juin 2025 (17h50) – Ion Beam Applications SA (« IBA ») annonce que l’ensemble des résolutions proposées à ses actionnaires lors de l’Assemblée Générale Ordinaire tenue le 11 juin dernier ont été adoptées à l’unanimité. Parmi celles-ci figurent notamment : L’approbation des comptes annuels pour l’exercice clôturé le 31 décembre 2024 ;L’approbation de la proposition de dividende de 0,24 EUR par action.  Calendrier rel...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch